Drug-price Transparency in Communications (DTC) Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (May 13, 2019)
Drug-price Transparency in Communications (DTC) Act
This bill provides statutory authority for the Centers for Medicare & Medicaid Services rule titled Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency, published on May 10, 2019. The rule requires direct-to-consumer television advertisements for covered drugs and biologics under Medicare and Medicaid to include the list price of a 30-day supply or for a typical course of treatment, if the list price is at least $35 per month. The rule takes effect July 9, 2019.
What just happenedMay 13, 2019
Read twice and referred to the Committee on Finance. (text: CR S2791)
Who’s behind it
- Introduced in SenateMay 13, 2019
- May 13, 2019IntroReferral
Read twice and referred to the Committee on Finance. (text: CR S2791)
Finance Committee - May 13, 2019IntroReferral10000
Introduced in Senate